Results 151 to 160 of about 18,017 (247)

(R)-3-amidinophenylalanine-derived inhibitors of factor Xa with a novel active-site binding mode

, 2002
A putative nonsubstrate like binding mode of (R)-3- amidinophenylalanine derivatives to factor Xa, as derived from modeling experiments based on Xray analysis of their complexes with trypsin, was used to design a new generation of inhibitors.
Bode, W., Sperl, S., Mueller, M. M., Moroder, L., Stürzebecher, J.   +4 more
core  

Peak and Trough Concentration Ranges of Factor Xa Inhibitors for Preventing Thromboembolic Stroke in Korean Patients with Non-valvular Atrial Fibrillation. [PDF]

Ann Lab Med
Park JS, Lim KH, Kim DH, Lee KM, Woo KS, Han JY.   +5 more
europepmc   +1 more source

Platelet-rich fibrin ensures hemostasis after single-tooth removal under factor Xa inhibitors - a clinical prospective randomized split-mouth study. [PDF]

Clin Oral Investig, 2023
Kyyak S, Jari A, Heimes D, Heider J, Kämmerer PW.   +4 more
europepmc   +1 more source

Impact of Factor Xa inhibitors on cardiovascular events in older patients with nonvalvular atrial fibrillation. [PDF]

Aging (Albany NY)
Takahashi M, Morimoto T, Tsushima R, Sudo Y, Sakamoto A, Sogo M, Ozaki M, Okawa K.   +7 more
europepmc   +1 more source

Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis. [PDF]

Cochrane Database Syst Rev, 2023
Wang X, Ma Y, Hui X, Li M, Li J, Tian J, Wang Q, Yan P, Li J, Xie P, Yang K, Yao L.   +11 more
europepmc   +1 more source

Endovascular Stenting and Factor Xa Inhibitors for Filter-Associated Chronic IVC Occlusion: A Case Series. [PDF]

Am J Case Rep
Cao P, Luo X, Gao R, Li Y, Li L, Zhang Y, Liu X.   +6 more
europepmc   +1 more source

Effect of PCC on Thrombin Generation among Patients on Factor Xa Inhibitors with Major Bleeding or Needing Urgent Surgery (GAUGE): Design and Rationale. [PDF]

TH Open, 2023
Shaw JR, Unachukwu U, Cyr J, Siegal DM, Castellucci LA, Dreden PV, Dowlatshahi D, Buyukdere H, Ramsay T, Carrier M.   +9 more
europepmc   +1 more source

Adverse Events of Factor Xa Inhibitors in Pediatric Patients: A Meta-analysis and Pharmacovigilance Study. [PDF]

Paediatr Drugs
Chong S, Sun L, Mu G, Hua M, Xiang Q, Cui Y.   +5 more
europepmc   +1 more source

The efficacy and safety of direct factor Xa inhibitors versus vitamin K antagonists for atrial fibrillation in patients on hemodialysis: a meta-analysis of randomized controlled trials. [PDF]

Proc (Bayl Univ Med Cent), 2023
Abuelazm M, Mahmoud A, Ali S, Gamal M, Elmezayen A, A Elzeftawy M, Abdelazeem B.   +6 more
europepmc   +1 more source

Factor Xa inhibitors versus vitamin K antagonist in morbidly obese patients with venous thromboembolism: a systematic review and meta-analysis. [PDF]

BMC Cardiovasc Disord, 2023
Park DY, An S, Arif AW, Sana MK, Vij A.
europepmc   +1 more source